FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2653674611> ?p ?o ?g. }

• W2653674611 endingPage "S50" @default.
• W2653674611 startingPage "S50" @default.
• W2653674611 abstract "Introduction: Post-transplant lymphoproliferative disorder (PTLD) is a serious complication following solid organ transplantation and highest incidence is reported in small bowel transplantation (SBTx)[1]. Reduction of immunosuppression (RIS), rituximab, and cytotoxic chemotherapy particularly for monomorphic PTLD are therapeutic options but are associated with systemic toxicity, risk of rejection and infection. Adoptive immunotherapy with Ebstein Barr virus-specific cytotoxic T-lymphocytes (EBV-CTL) is an effective treatment[2] but data in pediatric SBTx is scarce. Aim of the study is to review the outcome and long-term prognosis in pediatric patients who received EBV-CTL therapy for PTLD following SBTx in a tertiary pediatric transplant center. Method: Retrospective data were collected from medical records of pediatric patients who received EBV-CTL for PTLD following SBTx with or without combined liver transplantation (LTx), identified from a prospectively maintained patient database. PTLD was confirmed on histology based on World Health Organisation (WHO) criteria. The EBV-CTL were third-party sourced, human leucocyte antigen (HLA)-matched and obtained from an accredited national blood transfusion service. Results: Two patients were identified who underwent combined SBTx and LTx, and received EBV-CTL for PTLD between 1999 and 2001. Their primary disorders were Hirschsprung Disease (patient A) and congenital short bowel syndrome (patient B), both complicated by liver disease. Age at transplantation was 9 and 11 months respectively. Both were EBV seronegative pre-transplant, donor EBV serologies were unknown. Both had history of graft rejection prior to PTLD. Patient A was diagnosed 8 months after transplant with monomorphic PTLD from gastrointestinal (GI) and lymph node biopsies. Patient B was diagnosed 20 months after transplant with monomorphic PTLD in the GI tract. Both had persistent PTLD despite RIS. Both patients subsequently achieved complete histologic and radiologic remission of PTLD following treatment with third-party HLA-matched EBV-CTL with no adverse event. None developed graft-versus-host disease or opportunistic infections. No patient had recurrence of PTLD over 15 years of follow-up. Conclusion: We report the successful use of third-party HLA-matched EBV-CTL in achieving long-term remission of PTLD in 2 pediatric SBTx patients. EBV-CTL is a safe and effective adjunctive therapy in the treatment of monomorphic PTLD in pediatric SBTx. References: 1. Mynarek M, Schober T, Behrends U, Maecker-Kolhoff B. Posttransplant lymphoproliferative disease after pediatric solid organ transplantation. Clin Dev Immunol. 2013:814973. 2. Bollard CM, Rooney CM, Heslop HE. T-cell therapy in the treatment of post-transplant lymphoproliferative disease. Nat Rev Clin Oncol. 2012;9:510–519" @default.
• W2653674611 created "2017-06-30" @default.
• W2653674611 creator A5010972793 @default.
• W2653674611 creator A5031813680 @default.
• W2653674611 creator A5036764010 @default.
• W2653674611 creator A5056883490 @default.
• W2653674611 creator A5067453919 @default.
• W2653674611 date "2017-06-01" @default.
• W2653674611 modified "2023-10-18" @default.
• W2653674611 title "Successful Treatment Using Ebstein Barr Virus-Specific Cytotoxic T-Lymphocytes for Post-Transplant Lymphoproliferative Disorder in Pediatric Small Bowel Transplantation" @default.
• W2653674611 doi "https://doi.org/10.1097/01.tp.0000521350.72791.b0" @default.
• W2653674611 hasPublicationYear "2017" @default.
• W2653674611 type Work @default.
• W2653674611 sameAs 2653674611 @default.
• W2653674611 citedByCount "0" @default.
• W2653674611 crossrefType "journal-article" @default.
• W2653674611 hasAuthorship W2653674611A5010972793 @default.
• W2653674611 hasAuthorship W2653674611A5031813680 @default.
• W2653674611 hasAuthorship W2653674611A5036764010 @default.
• W2653674611 hasAuthorship W2653674611A5056883490 @default.
• W2653674611 hasAuthorship W2653674611A5067453919 @default.
• W2653674611 hasConcept C126322002 @default.
• W2653674611 hasConcept C141071460 @default.
• W2653674611 hasConcept C203014093 @default.
• W2653674611 hasConcept C2776995267 @default.
• W2653674611 hasConcept C2779338263 @default.
• W2653674611 hasConcept C2780252810 @default.
• W2653674611 hasConcept C2780653079 @default.
• W2653674611 hasConcept C2781146716 @default.
• W2653674611 hasConcept C2909675724 @default.
• W2653674611 hasConcept C2911091166 @default.
• W2653674611 hasConcept C71924100 @default.
• W2653674611 hasConcept C90924648 @default.
• W2653674611 hasConceptScore W2653674611C126322002 @default.
• W2653674611 hasConceptScore W2653674611C141071460 @default.
• W2653674611 hasConceptScore W2653674611C203014093 @default.
• W2653674611 hasConceptScore W2653674611C2776995267 @default.
• W2653674611 hasConceptScore W2653674611C2779338263 @default.
• W2653674611 hasConceptScore W2653674611C2780252810 @default.
• W2653674611 hasConceptScore W2653674611C2780653079 @default.
• W2653674611 hasConceptScore W2653674611C2781146716 @default.
• W2653674611 hasConceptScore W2653674611C2909675724 @default.
• W2653674611 hasConceptScore W2653674611C2911091166 @default.
• W2653674611 hasConceptScore W2653674611C71924100 @default.
• W2653674611 hasConceptScore W2653674611C90924648 @default.
• W2653674611 hasIssue "6S2" @default.
• W2653674611 hasLocation W26536746111 @default.
• W2653674611 hasOpenAccess W2653674611 @default.
• W2653674611 hasPrimaryLocation W26536746111 @default.
• W2653674611 hasRelatedWork W1480252831 @default.
• W2653674611 hasRelatedWork W1597668645 @default.
• W2653674611 hasRelatedWork W1982526890 @default.
• W2653674611 hasRelatedWork W2038808589 @default.
• W2653674611 hasRelatedWork W2054098715 @default.
• W2653674611 hasRelatedWork W2080180985 @default.
• W2653674611 hasRelatedWork W2120022197 @default.
• W2653674611 hasRelatedWork W2418258762 @default.
• W2653674611 hasRelatedWork W2578635055 @default.
• W2653674611 hasRelatedWork W4310163500 @default.
• W2653674611 hasVolume "101" @default.
• W2653674611 isParatext "false" @default.
• W2653674611 isRetracted "false" @default.
• W2653674611 magId "2653674611" @default.
• W2653674611 workType "article" @default.